What is UroGen Pharma's net change in cash?

UroGen Pharma (URGN) reported net change in cash of -$800K in Q1 2026.

How has UroGen Pharma's net change in cash changed year-over-year?

UroGen Pharma's net change in cash increased by 98.8% year-over-year, from -$67.95M to -$800K.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

UroGen Pharma URGN Net Change in Cash

Net Change in Cash at other companies

Bristol-Myers SquibbBMY

-$635M-220%

PfizerPFE

$563M+50.1%

Johnson & JohnsonJNJ

$1.98B-86.2%

Merck & Co.MRK

-$9.29B-103%

ImmunityBio, Inc.IBRX

$117.04M+241%

Tyra Biosciences, Inc.TYRA

$7.57M-13.6%

Other financials

Income statement

See full

Revenue$51.0M+152%

Gross profit$11.6M—

Operating income-$22.8M—

Net income-$23.6M+46.2%

EPS (diluted)-$1.17—

Balance sheet

See full

Cash & equivalents$110.0M+5.7%

Total debt$197.1M+56.0%

Total equity-$124.3M-167%

Total assets$253.7M+2.5%

Cash flow

See full

Operating cash flow-$45.3M-7.8%

CapEx$54.0K+22.7%

Free cash flow-$45.4M-7.8%

Valuation

See full

Market cap$1.73B+71.7%

Enterprise value$1.81B+80.9%

P/S12.3×+1.3×

Profitability

See full

Gross margin89.7%—

Operating margin-329.7%—

Net margin-94.8%-25.6pp

FCF margin-118.2%+1.3pp

Returns & leverage

See full

Return on equity-211.6%—

Debt / equity4.8×—

Current ratio4.7×-1.0×

Where this comes from

Reported directly by UroGen Pharma in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about UroGen Pharma's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is UroGen Pharma's net change in cash?: UroGen Pharma (URGN) reported net change in cash of -$800K in Q1 2026.
How has UroGen Pharma's net change in cash changed year-over-year?: UroGen Pharma's net change in cash increased by 98.8% year-over-year, from -$67.95M to -$800K.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.